Man Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Sell
90,259
-53,063
-37% -$260K ﹤0.01% 2026
2026
Q1
$490K Buy
+143,322
New +$483K ﹤0.01% 2085
2025
Q4
Sell
-80,197
Closed -$558K 2248
2025
Q3
$558K Buy
+80,197
New +$565K ﹤0.01% 1832
2025
Q2
Sell
-18,706
Closed -$120K 2170
2025
Q1
$120K Buy
+18,706
New +$180K ﹤0.01% 2098
2022
Q4
Sell
-31,443
Closed -$290K 2002
2022
Q3
$290K Buy
+31,443
New +$381K ﹤0.01% 1674
2022
Q2
Hold
0
1636

Other funds holding ASPN

Man Group's ASPN Position: Q2 2026 in Review

Man Group reduced its Aspen Aerogels (ASPN) stake by 37% in Q2 2026, selling an estimated $260K and leaving 90,259 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

Man Group first reported a position in ASPN in Q3 2022 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Man Group held 90,259 shares of Aspen Aerogels worth $572K as of Q2 2026.
  • Man Group sold 53,063 Aspen Aerogels shares in Q2 2026, an estimated $260K.
  • Aspen Aerogels made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2026 holding.
  • Man Group first reported a position in Aspen Aerogels in Q3 2022 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.